tiprankstipranks
Trending News
More News >
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market
Advertisement

Candel Therapeutics (CADL) Ownership - Who Owns Candel Therapeutics?

Compare
340 Followers

Candel Therapeutics (CADL) Ownership Overview

20.35%15.59%1.46%5.83%56.77%
20.35% Insiders
1.46% Other Institutional Investors
5.83% ETFs
56.77% Public Companies and
Individual Investors
The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail, and individual investors. Approximately 22.88% of the company’s stock is owned by Institutional Investors, 20.35% is owned by Insiders, and 56.77% is owned by Public Companies and Individual Investors.
The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail, and individual investors. Approximately 17.04% of the company’s stock is owned by Institutional Investors, 20.35% is owned by Insiders, and 5.83% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 17, 2025
xxxxxxxxxxxxx
$75290
Jan 17, 2025
xxxxxxxxxxxxx
$103405
Jan 17, 2025
xxxxxxxxxxxxx
$68669
Jan 17, 2025
xxxxxxxxxxxxx
$97715

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$101174
Mar 31, 2025
xxxxxxxxxxxxx
$13770117

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,544,979Institution10.40%37,983,106
5,197,821Insider9.75%35,605,074
4,431,832Insider8.31%30,358,049
2,437,189Institution4.57%16,694,745
1,540,692Institution2.89%10,553,740
1,423,128Institution2.67%9,748,427
1,356,174Institution2.54%9,289,792
546,863Insider1.03%3,746,012
370,797Institution0.70%2,539,959
315,222Institution0.59%2,159,271

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,544,979Institution10.40%37,983,106
1,356,174Institution2.54%9,289,792
370,797Institution0.70%2,539,959
315,222Institution0.59%2,159,271
216,345Institution0.41%1,481,963
120,026Institution0.23%822,178
105,633Institution0.20%723,586
83,880Institution0.16%574,578
76,136Institution0.14%521,532
17,664Institution0.03%120,998

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
991,077Institution1.86%6,194,231
866,650Institution1.63%4,385,249
566,665Institution1.06%2,867,325
314,607Institution0.59%1,966,294
200,246Institution0.38%1,013,245
86,877Institution0.16%542,981
31,823Institution0.06%161,024
30,567Institution0.06%191,044
24,495Institution0.05%167,791
21,364Institution0.04%137,371

FAQ

Who Owns Candel Therapeutics (CADL)?
According to the latest TipRanks data, approximately 1.46% of the company's stock is held by institutional investors, 20.35% is held by insiders, and 56.77% is held by retail investors.
    What percentage of Candel Therapeutics (CADL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.46% of Candel Therapeutics (CADL) stock is held by institutional investors.
      What percentage of Candel Therapeutics (CADL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 56.77% of Candel Therapeutics (CADL) stock is held by retail investors.
        Who owns the most shares of Candel Therapeutics (CADL)?
        Fidelity Select Portfolios owns the most shares of Candel Therapeutics (CADL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis